KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in IntangiblesChange in IntangiblesDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Dividends Paid - Common (2016 - 2026)

Gsk has reported Dividends Paid - Common over the past 18 years, most recently at -$866.9 million for Q1 2026.

  • For Q1 2026, Dividends Paid - Common fell 12.46% year-over-year to -$866.9 million; the TTM value through Mar 2026 reached -$1.7 billion, down 42.76%, while the annual FY2025 figure was $3.4 billion, 8.72% up from the prior year.
  • Dividends Paid - Common for Q1 2026 was -$866.9 million at Gsk, down from -$520.1 million in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $6.0 billion in Q4 2022 and troughed at -$1.3 billion in Q1 2022.
  • A 5-year average of -$31.1 million and a median of -$211.2 million in 2023 define the central range for Dividends Paid - Common.
  • Biggest five-year swings in Dividends Paid - Common: skyrocketed 1976.03% in 2022 and later tumbled 216.57% in 2025.
  • Year by year, Dividends Paid - Common stood at $6.0 billion in 2022, then plummeted by 108.46% to -$511.4 million in 2023, then surged by 67.87% to -$164.3 million in 2024, then tumbled by 216.57% to -$520.1 million in 2025, then crashed by 66.68% to -$866.9 million in 2026.
  • Business Quant data shows Dividends Paid - Common for GSK at -$866.9 million in Q1 2026, -$520.1 million in Q4 2025, and -$133.6 million in Q3 2025.